[Federal Register Volume 61, Number 141 (Monday, July 22, 1996)]
[Notices]
[Page 37904]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-18472]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Development of Feasibility Testing of 
Interventions To Increase Health-Seeking Behaviors in, and Health Care 
for Populations at High Risk for Gonorrhea, Program Announcement 638: 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Disease, Disability, and Injury Prevention and Control 
SEP: Development of Feasibility Testing of Interventions to Increase 
Health-Seeking Behaviors in, and Health Care for Populations at High 
Risk for Gonorrhea, Program Announcement 638.
    Time and Date: 8:30 a.m.-5 p.m., August 28-29, 1996.
    Place: 12 Corporate Square, Building 12, Conference Rooms 3106 
and 3110, Corporate Square Boulevard, Atlanta, Georgia 30329.
    Status: Closed.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement 638.
    The meeting will be closed to the public in accordance with 
provisions set froth in 5 U.S.C. Section 552b(c) (4) and (6), and 
the Determination of the Associate Director for Management and 
Operations, CDC, pursuant to Public Law 92-463.
    Contact Person for More Information: John R. Lehnherr, Chief, 
Prevention Support Office, National Center for HIV, STD, and TB 
Prevention, CDC, 1600 Clifton Road, NE, M/S E07, Atlanta, Georgia 
30333, telephone 404/639-8025.

    Dated: July 16, 1996.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 96-18472 Filed 7-19-96; 8:45 am]
BILLING CODE 4163-18-M